Who
Janet Jill Hopkins
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Aura Biosciences.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $429K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Nov 2023
- Last trade
- 1 Sep 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 1 Sep 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —58,850 at $0.00 | filing |
| 1 Sep 2026filed 1 Sep 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —116,150 at $0.00 | filing |
| 1 Sep 2026filed 1 Sep 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —116,150 at $0.00 | filing |
| 1 Sep 2026filed 1 Sep 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —58,850 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —89,056 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,944 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,944 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —89,056 at $0.00 | filing |
| 17 Feb 2026filed 17 Feb 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $103K20,401 at $5.06 | filing |
| 17 Feb 2026filed 17 Feb 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $103K20,401 at $5.06 | filing |
| 17 Nov 2025filed 17 Nov 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $93K17,109 at $5.42 | filing |
| 18 Feb 2025filed 18 Feb 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $20K2,534 at $7.75 | filing |
| 3 Feb 2025filed 4 Feb 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —79,365 at $0.00 | filing |
| 3 Feb 2025filed 4 Feb 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —120,635 at $0.00 | filing |
| 18 Nov 2024filed 18 Nov 2024 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $111K11,822 at $9.36 | filing |
| 1 Feb 2024filed 2 Feb 2024 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,485 at $0.00 | filing |
| 1 Feb 2024filed 2 Feb 2024 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —28,515 at $0.00 | filing |
| 1 Nov 2023filed 3 Nov 2023 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 1 Nov 2023filed 3 Nov 2023 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.